Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus-Reference-Cited by-同舟云学术

Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus

Published:2021-07-15 Issue:5 Volume:18 Page:418-421
ISSN:1570-1808
Container-title:Letters in Drug Design & Discovery
language:en
Short-container-title:LDDD

Author:

Rahbar Mohammad Reza¹,Gouvarchin Galeh Hadi Esmaeili²,Khalili Saeed³,Jahangiri Abolfazl⁴

Affiliation:

1. Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

2. Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

3. Department of Biology Sciences, Shahid Rajaee Teacher Training University, Tehran, Iran

4. Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

Abstract

The recent pandemic caused by a novel coronavirus known as SARS-CoV-2 has caught the international community by surprise. There is still no effective vaccine or treatment option against this virus. In this perspective, we discussed the potential protective and therapeutic effects of chitosan, as an FDA-approved biomolecule, against COVID-19 and influenza viruses.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications;Journal of Translational Medicine;2023-10-20

2. Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment;Pharmaceutics;2023-10-04

3. CHITIN AND CHITOSAN-BIOPOLYMER MATERIALS OF THE 21st CENTURY;PPOR;2023

4. Functionalized SPION immobilized on graphene-oxide: Anticancer and antiviral study;Diamond and Related Materials;2022-08

5. Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs;Biomolecules;2022-07-30